(Q37775038)

23 August 2017

1 reference

title

Polyphenolic compounds for treating neurodegenerative disorders involving protein misfolding (English)

1 reference

23 August 2017

1 reference

1

Lap Ho

1 reference

23 August 2017

author name string

Giulio Maria Pasinetti

series ordinal

2

1 reference

23 August 2017

publication date

1 August 2010

1 reference

Expert Review of Proteomics

23 August 2017

published in

1 reference

23 August 2017

volume

7

1 reference

23 August 2017

issue

4

1 reference

23 August 2017

page(s)

579-589

1 reference

Protein aggregation in Alzheimer's disease and other neoropathological disorders

23 August 2017

cites work

1 reference

Intracellular degradation of misfolded proteins in polyglutamine neurodegenerative diseases

21 January 2018

1 reference

Mechanisms of disease II: cellular protein quality control.

21 January 2018

1 reference

Pathological substrates of cognitive decline in Alzheimer's disease

21 January 2018

1 reference

Phosphorylation and cleavage of tau in non-AD tauopathies.

21 January 2018

1 reference

Cellular tau pathology and immunohistochemical study of tau isoforms in sporadic tauopathies

21 January 2018

1 reference

Immunological features of alpha-synuclein in Parkinson's disease

21 January 2018

1 reference

Pathophysiology of Huntington's disease: from huntingtin functions to potential treatments

21 January 2018

1 reference

Prefibrillar amyloid protein aggregates share common features of cytotoxicity.

21 January 2018

1 reference

Protein folding and misfolding on surfaces.

21 January 2018

1 reference

alpha-synuclein aggregation: a link between mitochondrial defects and Parkinson's disease?

21 January 2018

1 reference

Anthraquinones inhibit tau aggregation and dissolve Alzheimer's paired helical filaments in vitro and in cells

21 January 2018

1 reference

High throughput screening for small molecule inhibitors of heparin-induced tau fibril formation

21 January 2018

1 reference

Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease

21 January 2018

1 reference

Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins

21 January 2018

1 reference

Grape-derived polyphenolics prevent Abeta oligomerization and attenuate cognitive deterioration in a mouse model of Alzheimer's disease

21 January 2018

1 reference

Green tea (-)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models

21 January 2018

1 reference

Antioxidant compounds have potent anti-fibrillogenic and fibril-destabilizing effects for alpha-synuclein fibrils in vitro

21 January 2018

1 reference

The flavonoid baicalein inhibits fibrillation of alpha-synuclein and disaggregates existing fibrils

21 January 2018

1 reference

Characterization of inhibitor-bound alpha-synuclein dimer: role of alpha-synuclein N-terminal region in dimerization and inhibitor binding.

21 January 2018

1 reference

Inhibition of alpha-synuclein fibril assembly by small molecules: analysis using epitope-specific antibodies.

21 January 2018

1 reference

EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers

21 January 2018

1 reference

Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice.

21 January 2018

1 reference

Green tea epigallocatechin-3-gallate (EGCG) reduces beta-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice

21 January 2018

1 reference

Low dosage of rasagiline and epigallocatechin gallate synergistically restored the nigrostriatal axis in MPTP-induced parkinsonism

21 January 2018

1 reference

Simultaneous manipulation of multiple brain targets by green tea catechins: a potential neuroprotective strategy for Alzheimer and Parkinson diseases.

21 January 2018

1 reference

Effect of grape seed extract on blood pressure in subjects with the metabolic syndrome.

21 January 2018

1 reference

Subchronic 3-month oral toxicity study of grape seed and grape skin extracts

21 January 2018

1 reference

Consumption of grape seed extract prevents amyloid-beta deposition and attenuates inflammation in brain of an Alzheimer's disease mouse

21 January 2018

1 reference

Potential structure/function relationships of predicted secondary structural elements of tau.

21 January 2018

1 reference

Neurodegenerative tauopathies

21 January 2018

1 reference

MARKing tau for tangles and toxicity.

21 January 2018

1 reference

Toward a unified scheme for the aggregation of tau into Alzheimer paired helical filaments

21 January 2018

1 reference

Tau filaments from human brain and from in vitro assembly of recombinant protein show cross-beta structure

21 January 2018

1 reference

Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice

21 January 2018

1 reference

The formation of straight and twisted filaments from short tau peptides

21 January 2018

1 reference

Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.

21 January 2018

1 reference

Mutant huntingtin alters MAPK signaling pathways in PC12 and striatal cells: ERK1/2 protects against mutant huntingtin-associated toxicity.

21 January 2018

1 reference

Tau protein isoforms, phosphorylation and role in neurodegenerative disorders11These authors contributed equally to this work

21 January 2018

1 reference

Amyotrophic lateral sclerosis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/EPR.10.69

1 reference

23 August 2017

1 reference